 SOUTH PLAINFIELD, N.J., April 19, 2021 PRNewswire -- PTC Therapeutics, Inc. NASDAQ: PTCT today announced that on April 13, 2021 it approved non-statutory stock options to purchase an aggregate of 75,085 shares of its common stock and 33,740 restricted stock units RSUs, each representing the right to receive one share of its common stock upon vesting, to 79 new employees. 